Medical Research News

RSS

Study suggests two distinct versions of multiple sclerosis

There may be two distinct versions of multiple sclerosis, a study in both animal models and human blood samples suggests. What's more, a patient's responsiveness to the most popular first-line drug for this episodic and all-too-often recurring autoimmune condition seems to depend on which version that patient has.

30 Mar 2010

Chocolate can lower blood pressure and reduce risk of heart disease: Study

Easter eggs and other chocolate may be good for you - at least in small quantities and preferably if it's dark chocolate - according to research that shows just one small square of chocolate a day can lower your blood pressure and reduce your risk of heart disease. The study is published online today (Wednesday 31 March) in the European Heart Journal.

30 Mar 2010

Researchers find Dpp protein causes metastatic tumour migration

One of the most intriguing questions in cancer research is what causes metastatic tumour migration, why some tumour cells manage to migrate to other parts of the body but others cells don't. International investigation conducted by Enrique Mart-n Blanco, CSIC researcher at the Institute of Biology of Barcelona, located in the Barcelona Science Park, reveals that cells make use of a natural mechanism for this.

30 Mar 2010

Gout incidence lower in women than men: Study

Researchers from Boston University School of Medicine found that women with serum uric acid levels over 5 mg/dl had a significantly lower risk of developing gout than men. This study, the first to examine the relationship between uric acid levels and gout risk in women, also evaluated purported risk factors for gout and found that increasing age, obesity, hypertension, alcohol use, and diuretic use to be among leading contributors for women.

30 Mar 2010

Research: Having large number of supportive relatives increases fear of dying among elderly

Having a large number of supportive relatives increases the fear of dying among the elderly from ethnic minority groups, suggests research in Postgraduate Medical Journal.

30 Mar 2010

Few pregnant women meet physical activity guidelines set by health officials: Study

Fewer than 1 in 4 pregnant women meet physical activity guidelines set by doctors and health officials, according to a University of North Carolina at Chapel Hill study.

30 Mar 2010

Emory Institute of Drug Discovery and Zirus collaborate to develop new anti-viral drugs

The Emory Institute of Drug Discovery and Zirus, Inc., a biotechnology company based in Buford, Georgia, have entered into a collaboration and research agreement to develop novel compounds to treat infectious disease. Zirus uses a proprietary method for identifying genes and gene products in host cells that, when blocked, can prevent viruses from multiplying. Over the past several years, either alone or in collaboration with partners, including the Centers for Disease Control and Prevention (CDC), Zirus has identified, licensed and filed patents on more than 1000 targets.

30 Mar 2010

Study: Hormone replacement in joint fluid might be beneficial in treating osteoarthritis

German researchers determined that concentrations of the sex hormones, testosterone in men and estrogen in women, may have a positive effect on the regenerative potential of cartilage tissue. The study suggests hormone replacement in the joint fluid of men and women might be beneficial in treating late stages of human osteoarthritis by regenerating damaged tissue.

30 Mar 2010

Higher levels of CRP associated with brain changes: Study

New research shows that a high level of C-reactive protein, a marker for inflammation in the blood, is associated with brain changes that are linked to problems with executive thinking skills. The study is published in the March 30, 2010, issue of Neurology®, the medical journal of the American Academy of Neurology.

30 Mar 2010

In pregnant women, DVT more likely to occur on left side

Deep vein thrombosis (DVT) in pregnant patients is more likely to occur on the left side, and in particular in the left leg, write the authors of a Review article in CMAJ (Canadian Medical Association Journal) http://www.cmaj.ca/embargo/cmaj091692.pdf.

30 Mar 2010

Dicerna Pharmaceuticals, Ipsen announce collaboration in DsiRNA research and peptide engineering

Dicerna Pharmaceuticals, Inc., (Dicerna) a second generation RNA interference (RNAi) company, and Ipsen, a global biotechnology specialty care group, announced today that the two companies have entered into an exclusive research collaboration agreement to leverage their expertise in Dicer Substrate siRNA (DsiRNA) research and peptide engineering. The companies will develop novel conjugates of Dicerna's DsiRNA molecules and Ipsen's peptide targeting vectors in the therapeutic areas of oncology and endocrinology.

30 Mar 2010

Tomato genes could be used as future treatment in gene therapy: Study

Tomato genes could be used as a future treatment in gene therapy, according to new research results from Lund University.

30 Mar 2010

Research challenges current thinking about TB bacterium

Two new tuberculosis studies by UT Southwestern Medical Center researchers provide good news and bad news about the bacterium that infects nearly a third of the world's population and a disease that kills nearly 2 million people each year.

30 Mar 2010

Intellikine, Tragara Pharmaceuticals awarded $1M each for developing new multiple myeloma therapies

The Multiple Myeloma Research Foundation (MMRF) today announced that two San Diego area biotech firms, Intellikine and Tragara Pharmaceuticals, Inc. will receive funding via its MMRF Biotech Investment Award program. The MMRF Biotech Investment Awards represent a multi-year research grant commitment to fund the early-stage drug development of novel compounds and approaches that show potential in treating multiple myeloma. Based on the companies' achievement of clearly defined milestones, the MMRF will commit a total of $1,000,000 to each company by the end of 2011.

30 Mar 2010

National Institute of Mental Health awards two-year, $998,940 grant for autism research

An average of one in 100 children in the United States has an autism spectrum disorder according to the Centers for Disease Control and Prevention. While over the last few years an increasing number of these children have begun to receive early intervention services, research shows that high quality and intensive intervention are critical for positive outcomes.

29 Mar 2010

Celerion completes acquisition of MDS Pharma Services' early stage clinical development operations

Celerion, a privately owned contract research organization (CRO), has completed the acquisition of the development and regulatory services consultancy and early stage development operations of MDS Pharma Services. The acquired assets include five clinical research facilities and two bioanalytical laboratories located in Lincoln, Nebraska; Neptune, New Jersey; Phoenix, Arizona; Zurich, Switzerland; and Belfast, Northern Ireland, as well as operations in Richmond, Virginia and Quebec, Canada.

29 Mar 2010

New ezine to help ensure regulatory and ethical compliance in research involving lab animals

A new, free weekly ezine, Lab Animal e-Alert, helps scientists whose research involves lab animals assure regulatory and ethical compliance in their use. Its format is a reader question followed by an answer from an expert.

29 Mar 2010

Research explores association between BP and psychopathological symptoms

A paper published in the current issue of Psychotherapy and Psychosomatics addresses the relationship of body piercing with psychopathology. The term 'body piercing' refers to the 'insertion of jewellery and other objects into artificially made openings in body parts', while body modifications encompass BP and tattoos. Recent research has explored the association between BP and psychopathological symptoms with unclear results.

29 Mar 2010

DNA evidence often overwhelms jurors to convict wrongly says research

According to new reports from The Australian Institute of Criminology Research jurors are often not confident enough in their knowledge of DNA based evidence and this may often go against the accused as they may return with the guilty verdict. This is known as “the white coat syndrome” meaning laymen are often overwhelmed by the presence of an expert and as jurors may place more importance to these DNA evidence than necessary.

29 Mar 2010

Researchers evaluate the effect of chemical cocktails on humans and the environment

Throughout our lives we are exposed to an enormous range of man-made chemicals, from food, water, medicines, cosmetics, clothes, shoes and the air we breathe. At the request of the EU, researchers at the University of Gothenburg, Sweden, have looked at the risk of "chemical cocktails" and have proposed a number of measures that need to be implemented in the current practice of chemical risk assessment.

29 Mar 2010

Medical Research News

Study suggests two distinct versions of multiple sclerosis

Chocolate can lower blood pressure and reduce risk of heart disease: Study

Researchers find Dpp protein causes metastatic tumour migration

Gout incidence lower in women than men: Study

Research: Having large number of supportive relatives increases fear of dying among elderly

Few pregnant women meet physical activity guidelines set by health officials: Study

Emory Institute of Drug Discovery and Zirus collaborate to develop new anti-viral drugs

Study: Hormone replacement in joint fluid might be beneficial in treating osteoarthritis

Higher levels of CRP associated with brain changes: Study

In pregnant women, DVT more likely to occur on left side

Dicerna Pharmaceuticals, Ipsen announce collaboration in DsiRNA research and peptide engineering

Tomato genes could be used as future treatment in gene therapy: Study

Research challenges current thinking about TB bacterium

Intellikine, Tragara Pharmaceuticals awarded $1M each for developing new multiple myeloma therapies

National Institute of Mental Health awards two-year, $998,940 grant for autism research

Celerion completes acquisition of MDS Pharma Services' early stage clinical development operations

New ezine to help ensure regulatory and ethical compliance in research involving lab animals

Research explores association between BP and psychopathological symptoms

DNA evidence often overwhelms jurors to convict wrongly says research

Researchers evaluate the effect of chemical cocktails on humans and the environment

How can microdialysis benefit drug development

Global and Local Efforts to Take Action Against Hepatitis

Addressing Important Cardiac Biology Questions with Shotgun Top-Down Proteomics

Latest News